Below is an up-to-date list of 17 US-based biotech incubators currently supporting the next generation of scientists and researchers. In 2001, Mark Schweiker, Pennsylvania’s governor at the time, awarded $7.9 million to the Hepatitis B Foundation in a move to fund the development of a biotech center in Bucks County, PA. Through this partial funding, the Pennsylvania Biotechnology Center was born, a nonprofit life sciences incubator fostering and supporting the advancement of biotechnology in Bucks County and the neighboring region. It is managed by the Baruch S. Blumberg Institute. More here.
Louis P. Kassa III, MPA, CEO of the Hepatitis B Foundation, Baruch S. Blumberg Institute and Pennsylvania Biotechnology Center (PABC), today called the choice of John F. Crowley, JD, MBA, executive chairman, Amicus Therapeutics, to be president and CEO of BIO “a brilliant decision that will produce tangible benefits to the biotech industry.” Please read more here.
Gov. Josh Shapiro, in his first 100 days in Pennsylvania's top job, visited the PABC on April 27 with Rick Siger, acting secretary of the Department of Community and Economic Development. Five days later he shared on social media a positive review of our operation. Please watch it here. His office's news release is here.
Brandywine Realty Trust (NYSE: BDN) and Pennsylvania Biotechnology Center (PABC) announce B+labs at Cira Centre is not only open but fully leased. The list of life science leaders occupying the B+labs community includes 3D Systems, Asklepios Biopharmaceutical (AskBio), BriaCell Therapeutics Corp., Carisma Therapeutics, Ceptur Therapeutics, Quanta Therapeutics, Synapticure, Tmunity Therapeutics, Vetigenics, and Vitara Biomedical, among others. Please read more here.
For the second consecutive year, Louis P. Kassa III, MPA, chief executive officer of the Hepatitis B Foundation, Baruch S. Blumberg Institute and Pennsylvania Biotechnology Center (PABC), has been chosen by the Philadelphia Business Journal for its Power 100 list, which is being released this week. Kassa became named CEO of the organizations on July 1, 2022, succeeding co-founder Timothy M. Block, PhD. In 2019, Dr. Block was named by the Philadelphia Business Journal to its Power 100 list.
Learn More